Clinical Trial: A Comparative Analysis of the Efficacy and Safety of Ceftazidime/Avibactam for Sepsis Caused by Carbapenem-Resistant Gram-Negative Bacilli in Different Infection Sites (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Comparative Analysis of the Efficacy and Safety of Ceftazidime/Avibactam for Sepsis Caused by Carbapenem-Resistant Gram-Negative Bacilli in Different Infection Sites'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130759

Registration Time: 2026/08/24

Type: Observational study

Primary Sponsor: Wuxi people’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338967

Published by HT Digital Content Services with permission from Health Daily Digest....